EMVision Medical Devices Ltd
ASX: EMV.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Scott Philip Kirkland
- Employees
- 46
- Headquarters
- Macquarie Park, Australia
- IPO year
- 2018
- Market cap
- A$177.3M
- Website
- https://www.emvision.com.au
Loading EMV…
Loading profile data…Frequently asked questions about EMV
What does EMVision Medical Devices Ltd (EMV.AX) do?
EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis, monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park,...
Where does EMV.AX trade?
EMVision Medical Devices Ltd (EMV.AX) trades on the Australian Securities Exchange.
What sector is EMV.AX in?
EMVision Medical Devices Ltd (EMV.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of EMVision Medical Devices Ltd?
Scott Philip Kirkland is the chief executive officer of EMVision Medical Devices Ltd (EMV.AX).
Where is EMVision Medical Devices Ltd headquartered?
EMVision Medical Devices Ltd is headquartered in Australia.
Does EMV.AX pay a dividend?
EMVision Medical Devices Ltd (EMV.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EMV.AX go public?
EMVision Medical Devices Ltd (EMV.AX) completed its initial public offering in 2018.